Siramesine, a non-opioid sigma 2 receptor agonist as a potantial agent for development of novel target treatments for pancreatic cancer.


Sereti E., Koutsougianni F., Pesic M., Dinic J., Divac A., Armutak E. İ., ...More

5th Congress of the “Serbian Association for Cancer Research – SDIR, Belgrade, Serbia, 03 December 2021, pp.25, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • City: Belgrade
  • Country: Serbia
  • Page Numbers: pp.25
  • Istanbul University-Cerrahpasa Affiliated: Yes